Blue Origin said it was launching its own space satellite network in late 2027. Both AST SpaceMobile and EchoStar fell on the news. Trading at a triple-digit sales multiple, AST is a speculative stock ...
AST SpaceMobile stock (NASDAQ:ASTS) – a company developing a low-Earth-orbit (LEO) satellite constellation to provide broadband directly to smartphones – experienced a 14% increase in stock value on ...
A prediction of commercial services "in 2026" is still pretty broad. But nonetheless it is a step forward for a company that has been bigging up its direct-to-cell credentials since the start of this ...
AST SpaceMobile has made solid progress in setting the foundation for its space-based cellular network. But if the company wants to compete with SpaceX’s Starlink, it needs to launch dozens of ...
AST SpaceMobile, Inc. ASTS was awarded a contract for the Missile Defense Agency’s (MDA) Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) Program. This contract enables the company to ...
CAPE CANAVERAL SPACE FORCE STATION — For those who woke up early on Thursday morning, they got to see SpaceX launch AST SpaceMobile’s five commercial satellites despite the weather not looking ...
AST SpaceMobile’s next BlueBird satellite (#7/FM2) launch will be aboard a Blue Origin New Glenn rocket. There had been speculation that a SpaceX Falcon 9 rocket would be used, but it seems that ...
AST SpaceMobile, Inc. (ASTS) ended the recent trading session at $103.50, demonstrating a -7.95% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
When he's not battling bugs and robots in Helldivers 2, Michael is reporting on AI, satellites, cybersecurity, PCs, and tech policy.
Nonalcoholic fatty liver disease (NAFLD), also called metabolic dysfunction-associated steatotic liver disease (MASLD), can progress from simple fat buildup to inflammation, scarring, cirrhosis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results